article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.

BioTech 144
article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?

BioTech 270
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wellness in 2023 Is About Connections, Mental Health and Science – Global Wellness Summit’s 2023 Trends

Health Populi

Whether looking at biotech beauty and what “clean” really means, effectively dealing with obesity, or biohacking our biology, wellness-engaged health citizens are not interesting in the shiny new thing without data backing up claims. Being Missourian in spirit and intent: seeking the science and the evidence.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Stacy regularly advises on how COVID innovations such as telehealth need to remain as permanent options to enhance patient care. Connect with her at [link].

BioTech 107
article thumbnail

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Digital Health Global

The Relationship to TeleHealth 5.3.7 ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 Central Lab 4.3.4 Physician Office Lab’s 4.3.4.1 The Problem with POLS 4.3.5 Physician’s and OCT/DTC 4.3.6 Pharmacies and OCT/DTC 4.3.6.1 The Theranos Legacy 5 Market Trends 5.1 Biocartis 7.14

BioTech 88
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.